Publications by authors named "Inger Andreasson"

Claim this Profile
V
Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study.
Katalin Boér, István Láng, Antonio Llombart-Cussac, Inger Andreasson, Guillermo L Vivanco

Invest New Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis